A Randomized Placebo Controlled Trial of Duloxetine for Central Pain in Multiple Sclerosis.

Trial Profile

A Randomized Placebo Controlled Trial of Duloxetine for Central Pain in Multiple Sclerosis.

Completed
Phase of Trial: Phase II/III

Latest Information Update: 06 Feb 2013

At a glance

  • Drugs Duloxetine (Primary)
  • Indications Central pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 May 2011 Planned end date changed from 1 Apr 2011 to 1 Jun 2012 as reported by ClinicalTrials.gov.
    • 18 May 2010 Eli Lilly added as trial sponsor and lead trial center as as reported by ClinicalTrials.gov.
    • 18 May 2010 Planned end date changed from Apr 2009 to Apr 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top